Page 1 of Clinical Trials for platinum-sensitive recurrent ovarian cancer, 59 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
Last Updated: May 14, 2012
Condition(s): Ovarian Cancer
2
Not yet recruiting
Carboplatin and Pegylated Liposomal Doxorubicin With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
Last Updated: July 4, 2011
Condition(s): Ovarian Cancer
3
Recruiting
Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer
Last Updated: July 1, 2011
Condition(s): Ovarian Cancer
4
Recruiting
Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
Last Updated: May 14, 2012
Condition(s): Ovarian Cancer Recurrent
5
Completed
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer
Last Updated: February 11, 2011
Condition(s): Ovarian Cancer
6
Completed
IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Last Updated: April 28, 2012
Condition(s): Ovarian Epithelial Cancer Recurrent
7
Terminated
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
Last Updated: April 4, 2012
Condition(s): Ovarian Cancer
8
Recruiting
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Last Updated: February 24, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Malignant Tumor of Peritoneum
9
Completed
ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Last Updated: November 8, 2011
Condition(s): Ovarian Neoplasms
10
Active, not recruiting
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Last Updated: May 3, 2012
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
11
Completed
A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers
Last Updated: July 7, 2011
Condition(s): Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
12
Terminated
Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer
Last Updated: December 10, 2009
Condition(s): Ovarian Cancer
13
Recruiting
Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer
Last Updated: July 7, 2011
Condition(s): Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
14
Not yet recruiting
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Last Updated: May 16, 2012
Condition(s): Ovarian Cancer
15
Recruiting
A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma
Last Updated: November 25, 2011
Condition(s): Ovarian Carcinoma; Relapse
16
Active, not recruiting
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma
Last Updated: September 26, 2011
Condition(s): Ovarian Cancer
17
Completed
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
Last Updated: March 25, 2011
Condition(s): Ovarian Cancer
18
Recruiting
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Last Updated: April 2, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Malignant Tumor of Peritoneum
19
Terminated
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
Last Updated: September 13, 2006
Condition(s): Ovarian Cancer; Peritoneal Cancer
20
Completed
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=platinum-sensitive+recurrent+ovarian+cancer

Page 1 of Clinical Trials for platinum-sensitive recurrent ovarian cancer, 59 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About